Hemofarm Executive and Leadership Team

Ronald Seeliger, the Chief Executive Officer at Hemofarm, directs the overarching corporate strategy and manufacturing excellence for the organization. Overseeing the production of over 4 billion tablets and capsules annually, the Chief Executive Officer ensures that operational output meets rigorous international quality standards. This leadership role involves coordinating with the Board to maintain the 17.3% market share currently held within the Serbian pharmaceutical landscape. By optimizing supply chain efficiency and manufacturing throughput, Ronald Seeliger directly impacts the company's ability to scale production capacity. Furthermore, the Chief Executive Officer manages the integration of advanced pharmaceutical technologies to sustain competitive advantages. Through consistent focus on operational precision, Seeliger secures the long-term viability of the manufacturing infrastructure while driving the company toward increased output targets and enhanced market penetration across the broader regional pharmaceutical sector.

Dr. Seeliger, the President & Chief Executive Officer, Stada Balkan Cluster & Hemofarm at Hemofarm, architects the strategic vision for the entire Balkan cluster. Managing the 79.1% export share of Serbian medicinal products, the President & Chief Executive Officer, Stada Balkan Cluster & Hemofarm drives international expansion initiatives across diverse regional markets. This leadership role requires constant alignment with global Stada objectives while maintaining local market dominance. By fostering cross-border partnerships and navigating complex regulatory environments, Dr. Seeliger ensures that the company remains the premier exporter of pharmaceutical goods. The President & Chief Executive Officer, Stada Balkan Cluster & Hemofarm also oversees the harmonization of regional business units to maximize operational synergy. Through the implementation of high-level growth strategies, Seeliger strengthens the company's footprint, ensuring that the organization remains the primary provider of essential healthcare solutions throughout the entire Balkan region.

Vidosava Aleksic, the Chief Financial Officer, Pomocnik at Hemofarm, directs all fiscal planning, capital allocation, and financial reporting processes. Overseeing the financial health of the organization, the Chief Financial Officer, Pomocnik ensures that the 17.3% market share translates into sustainable revenue growth and long-term profitability. This leadership role involves managing complex budgetary requirements for large-scale manufacturing operations and export logistics. By implementing robust financial controls and risk management frameworks, Vidosava Aleksic supports the company's ability to invest in new pharmaceutical technologies. The Chief Financial Officer, Pomocnik also collaborates with executive leadership to evaluate investment opportunities that align with the company's mission of improving public health. Through meticulous oversight of the balance sheet and cash flow management, Aleksic secures the financial stability necessary for the company to maintain its status as the leading pharmaceutical manufacturer in the region.

Tijana Marković, the Chief Marketing Officer, Fmd & Specialist at Hemofarm, architects the brand strategy and market positioning for the company's extensive portfolio of medicinal products. Overseeing the promotion of specialized pharmaceutical lines, the Chief Marketing Officer, Fmd & Specialist ensures that the company's commitment to health reaches key stakeholders and healthcare providers across the region. This leadership role involves analyzing market trends to identify growth opportunities within the competitive pharmaceutical landscape. By executing targeted marketing campaigns and managing product launches, Tijana Marković drives demand for the billions of tablets and capsules produced annually. The Chief Marketing Officer, Fmd & Specialist also coordinates with sales teams to ensure that marketing initiatives directly support the company's export goals and domestic market share objectives. Through strategic brand management, Marković strengthens the company's reputation as a trusted leader in the pharmaceutical industry, ensuring consistent engagement with the medical community.